Simona Degli Esposti
Moorfields Eye Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Simona Degli Esposti.
PLOS ONE | 2013
Sobha Sivaprasad; Roxanne Crosby-Nwaobi; Simona Degli Esposti; Tunde Peto; Ranjan Rajendram; Michel Michaelides; Philip Hykin
Background To describe structural and functional changes associated with diabetic macular oedema (DMO) treated with intravitreal bevacizumab over 24 months. Methods A post-hoc analysis of the data of 34 patients that completed 24 months follow-up in the intravitreal bevacizumab arm of a prospective, randomized controlled trial (BOLT study) was performed. The outcome measures previously used in clinical trials of intravitreal ranibizumab in DMO were employed to describe the visual acuity and macular thickness changes at 12 and 24 months. Results The standard outcomes of mean change in best corrected visual acuity (BCVA) and central macular thickness (CMT) in participants treated with bevacizumab were comparable to those reported in association with ranibizumab. However, exploratory analyses showed that thick maculae at baseline defined as CMT of ≥400 µm, remained significantly thicker than those <400 µm with intensive bevacizumab therapy, despite a comparable gain in visual acuity at both 12 and 24 months. The proportion of subjects that attained a dry macula doubled in both CMT groups between the 12 and 24-month time-points. Conclusions These findings provide valuable information both for clinical practice and trials. Further studies are required to investigate the impact of intravitreal bevacizumab on retinal thickness profiles in DMO.
Ocular Immunology and Inflammation | 2017
Aniruddha Agarwal; Rupesh Agrawal; Dinesh Visva Gunasekaran; Dhananjay Raje; Bhaskar Gupta; Kanika Aggarwal; Somasheila L. Murthy; Mark Westcott; Soon Phaik Chee; Peter McCluskey; H. Su Ling; Stephen C. Teoh; Luca Cimino; Jyotirmay Biswas; Shishir Narain; Manisha Agarwal; Padmamalini Mahendradas; Moncef Khairallah; Nicholas Jones; Ilknur Tugal-Tutkun; Kalpana Babu; Soumayava Basu; Ester Carreño; Richard W J Lee; Hassan Al-Dhibi; Bahram Bodaghi; Alessandro Invernizzi; Debra A. Goldstein; Carl P. Herbort; Talin Barisani-Asenbauer
ABSTRACT Purpose: To analyze the role of polymerase chain reaction (PCR) of ocular fluids in management of tubercular (TB) anterior, intermediate, posterior, and panuveitis. Methods: In Collaborative Ocular Tuberculosis Study (COTS)-1 (25 centers, n = 962), patients with TB-related uveitis were included. 59 patients undergoing PCR of intraocular fluids (18 females; 53 Asian Indians) were included. Results: 59 (6.13%) of COTS-1 underwent PCR analysis. PCR was positive for Mycobacterium TB in 33 patients (23 males; all Asian Indians). 26 patients were PCR negative (18 males). Eight patients with negative PCR had systemic TB. Anti-TB therapy was given in 18 negative and 31 PCR cases. At 1-year follow-up, five patients with positive PCR (15.15%) and three with negative PCR (11.54%) had persistence/worsening of inflammation. Conclusions: Data from COTS-1 suggest that PCR is not commonly done for diagnosing intraocular TB and positive/negative results may not influence management or treatment outcomes in the real world scenario.
Retina-the Journal of Retinal and Vitreous Diseases | 2017
Mali Okada; Anthony G. Robson; Catherine Egan; Ferenc B. Sallo; Simona Degli Esposti; Tjebo F. C. Heeren; Marcus Fruttiger; Graham E. Holder
Purpose: To investigate the electrophysiological features of macular telangiectasia Type 2 and their relationship to structure as determined by optical coherence tomography imaging. Methods: Forty-two eyes from 21 patients enrolled in the Macular Telangiectasia Natural History Observation Study were reviewed. All patients had full-field and pattern electroretinography (ERG; PERG) with some patients additionally having multifocal electroretinography (mfERG; N = 15) or electrooculography (N = 12). Multiple linear regression modeling assessed the relationship between the ellipsoid zone break size on optical coherence tomography and the central mfERG response. Results: Full-field ERG and electrooculography were normal in all eyes. Six eyes (14%) from five patients had subnormal PERG P50 amplitudes. Twenty-two of 30 eyes (73%) had reduced central or paracentral stimulus on mfERG. There was a significant correlation between ellipsoid zone break size and both the P1 amplitude (R2 = 0.37, P = 0.002) and P1:N1 ratio (R2 = 0.32, P = 0.002) of the central response on mfERG. Conclusion: The electrophysiological findings in macular telangiectasia Type 2 are those of localized central dysfunction and are consistent with the structural data available from imaging and histologic studies. The ellipsoid zone break size correlates with mfERG reduction. The reduced mfERG P1:N1 ratio is consistent with inner retinal dysfunction.
Archives of Ophthalmology | 2012
Ranjan Rajendram; Samantha Fraser-Bell; Andrew Kaines; Michel Michaelides; Robin Hamilton; Simona Degli Esposti; Tunde Peto; Catherine Egan; Catey Bunce; Richard David Leslie; Philip Hykin
Investigative Ophthalmology & Visual Science | 2012
Simona Degli Esposti; Catherine Egan; Catey Bunce; J. D. Moreland; Alan C. Bird; Anthony G. Robson
Investigative Ophthalmology & Visual Science | 2012
Simona Degli Esposti; Catherine Egan; Catey Bunce; J. D. Moreland; Alan C. Bird; Anthony G. Robson
Archive | 2017
Ranjan Rajendram; Samantha Fraser-Bell; Andrew Kaines; Michel Michaelides; Robin Hamilton; Simona Degli Esposti; Tunde Peto; Catherine Egan; Catey Bunce; Richard David Leslie; Philip Hykin
Investigative Ophthalmology & Visual Science | 2016
Ferenc B. Sallo; Irene Leung; Simona Degli Esposti; Traci E. Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C. Bird; Tunde Peto
Ocular Immunology and Inflammation | 2018
Rupesh Agrawal; Dinesh Visva Gunasekeran; Aniruddha Agarwal; Ester Carreño; Kanika Aggarwal; Bhaskar Gupta; Dhananjay Raje; Somasheila I. Murthy; Mark Westcott; Soon Phaik Chee; Peter McCluskey; Ho Su Ling; Stephen C. Teoh; Luca Cimino; Jyotirmay Biswas; Shishir Narain; Manisha Agarwal; Padmamalini Mahendradas; Moncef Khairallah; Nicholas Jones; Ilknur Tugal-Tutkun; Kalpana Babu; Soumayava Basu; Richard W J Lee; Hassan Al-Dhibi; Bahram Bodaghi; Alessandro Invernizzi; Debra A. Goldstein; Carl P. Herbort; Talin Barisani-Asenbauer
Investigative Ophthalmology & Visual Science | 2017
Maria K Gemenetzi; Maria Eleftheriadou; Simona Degli Esposti; Zaria Ali; Daren Hanumunthadu; Konstantinos Balaskas; Praveen J. Patel